VolitionRx Limited Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
VolitionRx Limited (VNRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 88.35% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-03-31
- VolitionRx Limited share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 88.35%.
- VolitionRx Limited share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2013 was 239.00%.
- VolitionRx Limited share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2011 was 190.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 88.35% 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 81.27% 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 81.27% 10-Q · filed 2025-08-14 | |||
| 2025-05-15 | 99.99% 10-K · filed 2026-03-31 | |||
| 2013-12-31 | 239.00% 10-K · filed 2015-03-18 | |||
| 2013-09-30 | 244.00% 10-Q · filed 2013-10-31 | |||
| 2012-12-31 | 132.00% 10-Q · filed 2013-05-06 | |||
| 2011-12-31 | 190.00% 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |